New Perspectives for Colorectal Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Deihimi S, Lev A, Slifker M, Shagisultanova E, Xu Q, Jung K
. BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations. Oncotarget. 2017; 8(25):39945-39962.
PMC: 5522275.
DOI: 10.18632/oncotarget.18098.
View
2.
Le D, Uram J, Wang H, Bartlett B, Kemberling H, Eyring A
. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med. 2015; 372(26):2509-20.
PMC: 4481136.
DOI: 10.1056/NEJMoa1500596.
View
3.
Mirza M, Monk B, Herrstedt J, Oza A, Mahner S, Redondo A
. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. N Engl J Med. 2016; 375(22):2154-2164.
DOI: 10.1056/NEJMoa1611310.
View
4.
Hughes S, Barbacid M
. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature. 1986; 319(6056):743-8.
DOI: 10.1038/319743a0.
View
5.
Passiglia F, Caparica R, Giovannetti E, Giallombardo M, Listi A, Diana P
. The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer. Expert Opin Investig Drugs. 2016; 25(4):385-92.
DOI: 10.1517/13543784.2016.1152261.
View